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Abstract
For the synthesis of m-sulfamoylbenzamide analogues, small molecules which are known for their bioactivity, a chemoselective
procedure has been developed starting from m-(chlorosulfonyl)benzoyl chloride. Although a chemoselective process in batch was
already reported, a continuous-flow process reveals an increased selectivity at higher temperatures and without catalysts. In total,
15 analogues were synthesized, using similar conditions, with yields ranging between 65 and 99%. This is the first automated and
chemoselective synthesis of m-sulfamoylbenzamide analogues.
Introduction
Small molecules are commonly used for their ability to regulate
or assist in different biological processes. Typically, drug devel-
opment starts with the screening of large libraries of relatively
similar compounds, where only milligrams of material are
needed for primary testing. Upon identification of a primary hit,
the synthetic protocol must then be quickly expanded to tens of
grams for early in vivo toxicity studies and hundreds of grams
for further toxicology studies and clinical trials [1]. These
swiftly changing requirements appear throughout the clinical
development of active pharmaceutical ingredients (APIs) and
place specific and conflicting burdens on synthetic protocols.
An early synthesis must be extremely fast and flexible, as cur-
rent high-throughput compound screening takes less than one
week for a set of 10,000 compounds [2], which is far beyond
the current synthetic capabilities. Once a suitable hit is identi-
fied on the other hand, the synthetic prerequisites change com-
pletely, and a robust and scalable protocol is needed. Over the
past few years, flow chemistry has emerged as a potential solu-
tion to these conflicting prerequisites [3-11]. Flow processing is
suitable for automation, thus allowing the fast synthesis of com-
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pound libraries, but as opposed to, e.g., combinatorial chem-
istry, the developed protocols are directly useful for scale-up. A
class of small molecules where these principles can apply for
are m-sulfamoylbenzamides. These compounds proved to be
effective against Huntington’s and Parkinson’s disease [12-14].
They inhibit the Sirtuin 2 (SIRT2) deacetlyse protein (Figure 1,
AK-1, AK-7) resulting in improved motor skills [12,13,15].
Furthermore, m-sulfamoylbenzamide analogues (Figure 1,
C2-8) are able to suppress polyglutamine (polyQ) aggregation
[14], which is a major cause of neurodegeneration in Hunt-
ington’s disease. Although there are numerous reports available
on the study of these analogues, an automated, chemoselective
alternative to the synthesis is not yet available.
Figure 1: m-Sulfamoylbenzamides as Sirtuin 2 inhibitors (SIRT2) or
suppressor of polyglutamine aggregation (polyQ).
The most common synthetic approach starts from m-(chlorosul-
fonyl)benzoic acid [15-17]. This synthetic approach is a two-
step procedure and therefore needs two subsequent work-up
steps, limiting the yield and resulting in a more time-consuming
synthetic approach. Yang et al. [18] reported a one-pot synthe-
tic strategy for m-sulfamoylbenzamide analogues starting from
m-(chlorosulfonyl)benzoyl chloride. In this study the difference
in reactivity between the sulfonyl and aroyl chloride is
exploited resulting in a chemoselective synthesis for these ana-
logues. The yields varied between 46% and quantitative yield,
relatively short reaction times were required and dichloro-
methane was used as solvent.
The coupling of carboxylic acids with amines in flow through a
benzotriazole activation [19], or with immobilized reagents as
for the synthesis of grossamide [20] is already known. How-
ever, we wanted to use m-(chlorosulfonyl)benzoyl chloride
since this can be synthesized in one single step. Furthermore,
acid chlorides show a high reactivity [21] making m-(chloro-
sulfonyl)benzoyl chloride an ideal starting material as was
shown by Yang et al. [18]. By transferring this reaction to a
multistep flow set-up, we envisioned an improved chemoselec-
tivity. This phenomenon is not unusual for flow chemistry.
Typical batch reactions are mixed by stirring; however, perfect
homogeneity is not immediately obtained. Ideal mixing condi-
tions can only be achieved with microreactors or micromixers
[22]. The small diameters of these microreactors lead to almost
ideal mixing conditions [23-26], resulting in an improved
chemoselectivity. Furthermore, the use of an automated process
leads to the possibility to produce libraries of compounds in a
fast manner. In addition, an alternate biocompatible and water
miscible solvent would result in a flexible and automated
chemoselective synthesis, delivering stock solutions suitable for
initial testing at the outlet of the reactor.
Results and Discussion
Development of a continuous-flow process
Although a continuous-flow process shows many advantages
compared to batch reactions, there are some difficulties which
should be overcome or be avoided. A general concern is the
clogging of the channels. There are numerous reports about
handling solids in flow. For example, the use of ultrasound [27-
32] can reduce the particle size of the precipitates, and
preventing the clogging of the small channels. A second exam-
ple is the Coflore agitating cell reactor [32]. This type of reactor
uses transverse mixing motions which keeps the solids in
suspension, and prevents clogging. The Coflore reactor was
successfully used for the synthesis of N-iodomorpholinium
hydroiodide salt [33]. However, it takes specialized machinery
and time to develop a system which can pump slurries. There-
fore, a reduction in the formation of solids is preferable.
Furthermore, we wanted to avoid the use of dichloromethane as
solvent and use a biocompatible and water miscible alternative.
A series of initial batch reactions were performed to evaluate
the potential of a chemoselective synthesis as a continuous
process. As bench mark, aniline and azepane were used as first
and second reagent, respectively. After addition of the first
reactant and completion of the reaction (followed by TLC) the
second reactant was added. The chemoselectivity was deter-
mined by LC–MS analysis.
In the initial screening, tetrahydrofuran (THF) was chosen as
solvent (cfinal = 100 mM), however, precipitation of the ammo-
nium salts was unavoidable. The results of this screening did
show that the use of catalysts, such as pyridine or dimethyl-
aminopyridine (DMAP), is unnecessary in batch or continuous
flow. This is not surprising since a similar result is reported for
the reaction of amines with sulfonyl chlorides [34]. Triethyl-
amine was added as base for the capture of hydrogen chloride
which is produced during the reaction. Nonetheless, the precipi-
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Table 1: Screening results of the different conditions for the best chemoselectivity with aniline and azepane as (F2) and (F3), respectively.
Run Flow rate 1 (µL/min) Flow rate 2 (µL/min) T1 (°C) Chemoselectivity (%)
1 50 100 0 91
2 75 150 0 80
3 25 50 10 89
4 50 100 10 91
5 75 150 10 93
6 100 200 10 92
7 125 250 10 89
8 75 150 20 92
9 100 200 20 93
10 125 250 20 94
batch – – 0 80a
batch – – 20 75a
aReaction performed in batch with a final concentration of 10 mM.
tation of anilinium salts and/or triethylamonium salts could
not be avoided in THF, even at lower concentrations
(cfinal = 10 mM). Due to the reactivity of the aroyl and sulfonyl
chloride, water, DMF or DMSO cannot be used to dissolve the
salts. Therefore, acetonitrile (CH3CN) was used instead.
CH3CN is a more polar solvent compared to THF, however, the
salts which were formed during the reaction still precipitated
(cfinal = 100 mM and 40 mM). At lower concentrations
(cfinal = 10 mM), the precipitation of the formed salts was not
observed. Furthermore, the chemoselectivity was increased,
being 80% for 10 mM and 73% for 100 mM.
Screening for the optimal chemoselectivity
Since the formation of precipitants can be avoided using
CH3CN at a final compound concentration of 10 mM, the syn-
thesis can be further optimized in continuous flow. To get the
optimal selectivity and reaction conditions, different parame-
ters were screened (residence time/flow rate and reactor temper-
ature). The advantage of the serial use of two microreactors is
that two different temperatures can be used. Three solutions
were made: F1 and F2 having a concentration of 40 mM, and F3
having a concentration of 20 mM. After addition of the three
reaction streams, with the flow rate of F3 being twice as high as
for F1 and F2, the final concentration is 10 mM. This corre-
sponds to the end concentration of the selected batch reaction.
The results of screening of residence time/flow rate and reactor
temperature are presented in Table 1. The optimal conditions
and selectivity are obtained for a flow rate of 125 µL/min for
starting materials 1 and 2a and 250 µL/min for reactant 2b. The
temperature for the first microreactor was kept at 20 °C to avoid
coupling with the sulfonyl chloride. The second reactor was
kept at 40 °C. This increase in temperature enables the cou-
pling with the less reactive sulfonyl chloride, and prevents the
use of catalysts.
With this process, an automated and chemoselective continu-
ous synthesis was obtained for m-sulfamoylbenzamide ana-
logues. Furthermore, the chemoselectivity was increased signif-
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Table 2: Screening results of the different conditions for the best chemoselectivity with azepane as (F2).
Run Flow rate (µL/min) Concentration F1 and F2 (mM) Final concentration (mM) 4 (%) 3bb (%)
1 50 40 20 29 36
2 100 40 20 29 36
3 200 40 20 28 36
4 50 20 10 37 32
5 100 20 10 60 20
6 150 20 10 47 27
7 100 10 5 63 19
8 150 10 5 71 15
9 200 10 5 64 18
10 200 5 2.5 67 17
11 400 5 2.5 74 13
12 600 5 2.5 82 9
icantly compared to the batch reaction due to the quasi-ideal
mixing conditions, and therefore avoiding coupling with the
sulfonyl chloride which is less reactive compared to the aroyl
chloride [35]. For the reactions in batch, an average chemose-
lectivity of 80% was obtained while for the synthesis in contin-
uous flow with CH3CN the average chemoselectivity is 94%.
This indicates that these optimized mixing conditions are
crucial for an improved chemoselective synthesis. Interestingly,
the temperatures used for the first coupling (T1 = 20 °C) are
substantially higher compared to the batch reactions (0 °C),
while the chemoselectivity is still maintained. This effect is also
linked to the optimized mixing conditions enabling higher tem-
peratures without losing chemoselectivity, while increasing the
reaction rate. This adds also significantly to an increased
sustainability of the process since no cooling capacity is re-
quired.
This process can be used for a range of m-sulfamoylbenzamide
analogues (vide infra). However, if the first reagent (F2) is a
secondary amine, the chemoselectivity decreases substantially
when the current process is used. Secondary amines are more
nucleophilic as compared to primary amines, resulting in a
higher percentage of sulfonylation. To improve the chemoselec-
tivity when using secondary amines, an additional screening
was performed with azepane and aniline as first and second
reagent, respectively. Initially, we tried to increase the selec-
tivity by decreasing the temperature. Unfortunately, the reac-
tion mixtures obtained showed the presence of several side
products, and the decrease in temperature did not appear to
result in a substantial increase in chemoselectivity. Therefore, it
was decided to first optimize the chemoselectivity for com-
pound 4 (Table 2). This simplified the reaction mixture substan-
tially. The temperature was kept at −15 °C and the final concen-
tration of compound 4 was varied between 20 mM and 5 mM.
By decreasing the concentration, the chemoselectivity in-
creased substantially from 45% for 40 mM to 89% for 5 mM.
Using the lower substrate concentration, an optimization of the
second reaction step was performed, using azepane as the first
and aniline as the second reactant. The concentrations used
were 5 mM for F1 and F2 and 2.5 mM for F3. This leads to a
final concentration of 1.25 mM. However, due to the increased
flow rate, the second coupling step with aniline could not reach
full conversion. Even by increasing the temperature for this step
up to 75 °C, full conversion was not obtained. Therefore,
DMAP was used as a base instead of triethylamine in F3.
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Table 3: Screening results of the different conditions for the best chemoselectivity with azepane and aniline as (F2) and (F3), respectively.
Run Flow rate 1 (µL/min) Flow rate 2 (µL/min) T1 (°C) Chemoselectivity (%)
1 300 600 −15 39
2 400 800 −15 79
3 500 1000 −15 57
4 300 600 0 53
5 400 800 0 80
6 500 1000 0 82
7 600 1200 0 52
8 200 400 10 41
9 300 600 10 50
10 400 800 10 40
batch – – 0 59a
aReaction performed in batch with a final concentration of 1.25 M.
DMAP serves both as a base and catalyst for the reaction with
the sulfonyl chloride group. The temperature in the second
reation chip was kept at 75 °C and by using DMAP as a base,
full conversion was obtained. The effect of the temperature and
the flow rate were evaluated and the results are shown in
Table 3. The highest chemoselectivity (82%) was obtained for a
flow rate of 500 µL/min for F1 and F2 and 1000 µL/min for F3
at a temperature of 0 °C and 75 °C in chip 1 and chip 2, respec-
tively. It should be noted that not the reaction temperature, but
rather the substrate concentration is the main variable deter-
mining chemoselectivity (compare Table 3, entries 2 and 5).
The chemoselectivity in flow was again higher compared to the
batch conditions due to quasi-ideal mixing conditions.
Medium-throughput synthesis
To evaluate the flexibility of both processes, a range of mole-
cules were synthesized on small scale. In total, 49 molecules
could be readily used for a medium-throughput screening for
pharmaceutical applications. The chemoselectivity was
measured by LC–MS and is presented in Table 4. The chemose-
lectivity varied between 50 and 99%. Apart from the reactions
involving 3-fluoroaniline, the chemoselectivity was above 70%
for primary amines and above 60% for secondary amines. The
side products which are being formed are the double substi-
tuted analogues 3aa, 3bb, 3cc, 3dd, 3ee, 3ff or 3ee depending
on the amines which were used. As such, we synthesized these
compounds (chemoselectivity >99%) so that they can function
as a negative control in the direct screening, to exclude false
positives. Synergistic effects were not taken into account but,
the screening of these analogues should already give a good in-
dication which compounds are of interest.
Medium throughput synthesis if F2 are primary
amines
Between each sample a washing step with CH3CN was included
to eliminate any side reaction of undesired amines in the
system. For the washing step, a flow rate of 1000 µL/min was
applied for a duration of 4 minutes. This implements a total
washing volume of 12 mL, which is 8 times the total volume of
the flow system. The equilibration time was 11.5 minutes and
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Table 4: Chemoselectivity (%) of the medium-throughput synthesis in continuous flow.
(F3)
2a 2b 2c 2d 2e 2f
2g
(F2)
2a
99
3aa
94
3ab
95
3ac
64
3ad
95
3ae
83
3af
94
3ag
2b
82
3ba
99
3bb
83
3bc
77
3bd
76
3be
70
3bf
74
3bg
2c
83
3ca
94
3cb
99
3cc
64
3cd
94
3ce
84
3cf
97
3cg
2d
64
3da
59
3db
53
3dc
99
3dd
58
3de
68
3df
85
3dg
2e
93
3ea
94
3eb
94
3ec
63
3ed
99
3ee
86
3ef
94
3eg
2f
77
3fa
73
3fb
71
3fc
50
3df
77
3fe
99
3ff
72
3fg
2g
68
3ga
69
3gb
83
3gc
63
3gd
60
3ge
61
3gf
99
3gg
the collecting time 1.5 minutes resulting in a reaction time of
13 minutes. The volume collected for each sample was 750 µL,
and a total reaction time, including the washing step, of
17 minutes is required. On a 24 h basis, a total of 84 com-
pounds can be synthesized in continuous flow, and used for a
medium-throughput screening with primary amines as first
reactant. The final concentration of each sample was 10 mM
and can be diluted with a factor 100 resulting in a concentration
of 100 µM. In each sample, only 1% (v/v) of CH3CN would be
present.
Medium throughput synthesis if F2 are secondary
amines
If the first reagent is a secondary amine, the washing step
remains the same and the volume collected was 1000 µL. The
equilibration time was 5 minutes and the collecting time
together with the equilibration time was 5 minutes and
20 seconds. The total reaction time, including the washing step,
was approximately 10 minutes. This leads to 144 compounds on
a daily basis. The final concentration of each sample was
1.25 mM and can be diluted with a factor 12.5 resulting in a
concentration of 100 µM. In each sample 8% (v/v) of CH3CN
would be present. The next step is to produce these compounds
on a larger scale. From Table 4, 15 analogues were chosen and
produced on a larger scale (vide infra).
Synthesis of a small library in continuous flow
The use of flow chemistry facilitated greatly the synthesis of an
extended library of compounds. Different m-sulfamoylbenz-
amide analogues were synthesized in continuous flow. From
Table 4, 15 analogues were produced on a larger scale to exem-
plify the direct scalability of the developed protocol. For these
reactions the required amount of product was aimed at
100–200 mg which took about 3 hours of production. Com-
pound 3cb, which corresponds with AK-7, was also produced
on gram scale which took approximately 24 hours. Table 5
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Table 5: Library of 15 m-sulfamoylbenzamide analogues synthesized in continuous flow.
Compound (F2) (F3) Chemoselectivity
(%)
Yield (%) Quantity (mg)
3aa – 95 140
3ab 94 75 197
3ac 95 78 94
3ae 95 76 92
3ag 94 74 88
3ca 83 70 83
3cb 9487a
78
80
93
2447
3cc – 99 97
3ce 94 81 77
3cg 97 77 96
3ea 93 80 96
3eb 94 78 94
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Table 5: Library of 15 m-sulfamoylbenzamide analogues synthesized in continuous flow. (continued)
3ec 94 72 87
3ee – 98 117
3eg 94 77 93
aReduced chemoselectivity due to leakage during the reaction.
Figure 2: Syrris AFRICA system.
shows 15 analogues synthesized in continuous flow. The
chemoselectivity varied between 83 and 97%, the remaining
17–3% were symmetrical m-sulfamoylbenzamides. After work-
up and purification the yield was between 70 and 99%. These
results indicate that both processes are applicable to a large
variety of m-sulfamoylbenzamides.
Conclusion
A chemoselective, automated process is developed for the syn-
thesis of m-sulfamoylbenzamide analogues. The used solvent is
acetonitrile and the reactions in continuous flow showed an in-
creased chemoselectivity compared to the batch reactions due to
the ideal mixing conditions. Using secondary amines, a de-
crease in substrate concentration was essential to selectively
obtain amides over sulfonamides. It was shown that the proce-
dure can easily be used for the synthesis of a compound library
suitable for initial screening; and that the optimized synthetic
conditions are directly transferrable should the resulting hits be
needed in gram-scale for further evaluation.
Experimental
General
All chemicals were purchased by either Sigma-Aldrich or TCI
chemicals. Commercially available products were used without
additional purification. NMR spectra were recorded at 400 MHz
(1H) and 100 MHz (13C) in CDCl3 with tetramethylsilane as
internal standard or DMSO-d6 on a Bruker Avance III Nanobay
400 MHz spectrometer at room temperature. The automated
continuous synthesis was conducted using a commercially
available continuous-flow system (syrris AFRICA, Figure 2).
Representative procedure for m-sulfamoyl-
benzamide analogues
a) Continuous process with primary amines as F1: Triethyl-
amine and a primary amine (F1) were dissolved in acetonitrile
(c = 40 mM), m-chlorosulfonylbenzoyl chloride (F2) was dis-
solved in the same solvent in a separate volumetric flask
(c = 40 mM). A third solution was prepared with triethylamine
and the second reactant (F3) (c = 20 mM). The flow process is
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presented in Table 1; reactants 1 and 2x were mixed together in
reactor 1 at 20 °C at a flow rate of 125 µL/min. The reaction
mixture was then pumped to reactor 2, which was kept at 40 °C.
The third reactant (2y) was then added at a flow rate of
250 µL/min. The residence times were 1 min and 2 min, respec-
tively. Once the mixture passed both reactors, the final com-
pound concentration was 10 mM and could be used as a stock
solution for initial screening. For the larger scale experiments,
the work-up procedure was similar to a batch reaction. The sol-
vent was removed in vacuo and the remaining oil was dis-
solved in diethyl ether. It was subsequently washed with a
hydrogen chloride solution of 1 M and with a saturated sodium
bicarbonate solution. The organic phase was dried with MgSO4,
the solvent was evaporated in vacuo, and the residue was puri-
fied by either preparative thin-layer chromatography or by
recrystallization.
b) Continuous process with secondary amines as F1: Triethyl-
amine and a secundary amine (F1) were dissolved in aceto-
nitrile (c = 5 mM), m-chlorosulfonylbenzoyl chloride (F2) was
dissolved in acetonitrile in a second volumetric flask
(c = 5 mM). A third solution was prepared with dimethylamino-
pyridine (DMAP) and the second reactant (F3) (c = 2.5 mM).
The flow process is presented in Table 3; reactants 1 and 2x
were mixed together in reactor 1 at 0 °C at a flow rate of
500 µL/min. The reaction mixture was then pumped to reactor
2, which was kept at 75 °C. The third reactant (2y) was then
added at a flow rate of 1000 µL/min. The residence times were
0.25 min and 0.5 min, respectively. Once the mixture passed
both reactors, the final compound concentration was 1.25 mM
and could be used as a stock solution for screening.
Supporting Information
Supporting Information File 1
Experimental part.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-13-33-S1.pdf]
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